A detailed history of Keynote Financial Services LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keynote Financial Services LLC holds 27,750 shares of BMY stock, worth $1.15 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
27,750
Holding current value
$1.15 Million
% of portfolio
1.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 13, 2024

BUY
$47.98 - $54.4 $1.33 Million - $1.51 Million
27,750 New
27,750 $1.5 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Keynote Financial Services LLC Portfolio

Follow Keynote Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keynote Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keynote Financial Services LLC with notifications on news.